The FDA presented switching rates as ranges rather than point estimates:
Complete Switching Rate at 6 Weeks (Adult Smokers → JUUL2)
Source: FDA CTP Newsroom, Aug. 28, 2026
FDA did not specify the basis for presenting the switching figures as ranges. Higher switching rates for menthol were cited as a key factor in the authorization decision.
The gap between the two flavors is significant: the menthol pod's floor (28.4%) exceeds the tobacco pod's ceiling (34.6%). This is the evidence the FDA used to justify authorizing a menthol-flavored product despite long-standing concerns about menthol's appeal to youth.
